Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nurami

Nurami?uq=UG6efJS6
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$652K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of nanofiber sealant technology intended to focus on the soft tissue repair market. The company's technology is used to develop a unique substitute patch for neurosurgeries to prevent cerebrospinal fluid leakage and to regenerate the damaged dura, protecting the brain, enabling physicians to treat in an enhanced way.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • P.O.B 1252
  • Nazareth Illit
  • Nazareth 1711102
  • Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nurami’s full profile, request a free trial.

Nurami Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 20-Dec-2016 $652K 00.000 Completed Startup
1. Seed Round 01-Jan-2014 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Nurami Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alfred Mann Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
Next Generation Technology Venture Capital Minority 000 0000 000000 0

Nurami Executive Team (2)

Name Title Board
Seat
Contact
Info
Amir Bahar Ph.D Co-Founder and Chief Executive Officer
Nora Nseir Co-Founder & Chief Technology Officer

Nurami Board Members (2)

Name Representing Role Since Contact
Info
Doron Birger Self Chairman 000 0000
Zohar Gendler Next Generation Technology Board Member 000 0000